Abstract:During respiratory-virus infection, excessive lymphocyte activation can cause pathology both in acute infection and in exacerbations of chronic respiratory diseases. The costimulatory molecule CD161 is expressed on lymphocyte subsets implicated in promoting respiratory inflammation, including Th2, Th17, mucosally associated invariant T (MAIT) cells, and type 2 innate lymphoid cells. We asked whether the CD161 ligand LLT1 could be expressed on respiratory epithelial cells following respiratory-virus infection as a mechanism by which respiratory-virus infection could promote activation of proinflammatory lymphocytes. In response to respiratory syncytial virus (RSV) infection, expression of LLT1 was upregulated in the BEAS-2B respiratory epithelial cell line and primary human bronchial epithelial cells. Imaging studies revealed that LLT1 expression increased in both RSV-infected and cocultured uninfected cells, suggesting that soluble factors produced during infection stimulate LLT1 expression. TLR3 and TLR2/6 ligands led to a rapid increase in LLT1 mRNA in respiratory epithelial cells, as did the proinflammatory cytokines type I interferons, interleukin 1β (IL-1β), and tumor necrosis factor alpha (TNF-α), which are produced early in respiratory-virus infection. Immunohistochemistry confirmed the increase in LLT1 protein on the epithelial cell surface, and live-cell confocal microscopy demonstrated accumulation of epithelial LLT1 at synapses formed with CD161(+) T lymphocytes. LLT1 expression by the respiratory epithelium in response to respiratory-virus infection and inflammatory cytokines represents a novel link between innate immunity and lymphocyte activation. As a regulator of CD161(+) proinflammatory lymphocytes, LLT1 could be a novel therapeutic target in inflammation caused by respiratory-virus infection. Importance: The immune response to respiratory-virus infection is essential for clearing the pathogen but, if excessive, can lead to tissue damage and obstruction of the airways. How viral infection activates immune cells in the lungs is not fully understood. Here, we show that LLT1 can be expressed in lung cells in response to infection. LLT1 triggers CD161, a receptor on inflammatory immune cells. This mechanism may promote activation of immune cells in the lungs in viral infection and could be a novel target for therapies aimed at reducing lung inflammation.

Epithelial memory after respiratory viral infection results in long-lasting enhancement of antigen presentation

[Airway Inflammation Induced by Poly(I:C) Stimulation in the Late Stage of Respiratory Syncytial Virus Infection in Mice and Its Mechanism].

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

Involvement of Epigenetic Modification in Epithelial Immune Responses During Respiratory Syncytial Virus Infection

Activation of Lymphocytes Induced by Bronchial Epithelial Cells with Prolonged RSV Infection

Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection

Respiratory Syncytial Virus Infection Provokes Airway Remodelling in Allergen-Exposed Mice in Absence of Prior Allergen Sensitization

Progressive Changes in Inflammatory and Matrix Adherence of Bronchial Epithelial Cells with Persistent Respiratory Syncytial Virus (RSV) Infection (progressive Changes in RSV Infection)

Respiratory syncytial virus infection, TLR3 ligands, and proinflammatory cytokines induce CD161 ligand LLT1 expression on the respiratory epithelium

Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection

Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases

Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection

Innate memory against viruses

Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells

Early-Life Respiratory Syncytial Virus (RSV) Infection Triggers Immunological Changes in Gut-Associated Lymphoid Tissues in a Sex-Dependent Manner in Adulthood

Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF

Epithelial plasticity and innate immune activation promote lung tissue remodeling following respiratory viral infection

Prevention of respiratory virus transmission by resident memory CD8+ T cells

TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells

Epigenetic Control of Innate Immunity: Consequences of Acute Respiratory Virus Infection

Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function